Asiri Hospital Holdings PLC

  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: LK0010N00005
LKR
30.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Asiri Hospital Holdings PLC stock-summary
stock-summary
Asiri Hospital Holdings PLC
Hospital
Asiri Hospital Holdings PLC is engaged in providing healthcare and hospital services. The Company operates a hospital, provides healthcare services, and manages and holds investments in the healthcare industry. The Company provides its tests in various areas, such as chemical pathology, biochemistry, clinical pathology, hematology, microbiology, histology and immunology. The Company offers various services, which include critical care wards, neonatal intensive care unit, dialysis unit, operating theaters, intensive care unit, e-channeling consultation, emergency medical service unit, ultrasound scanning, echocardiography with two dimension (2D) Doppler analysis, pharmacy, mobile electrocardiogram, mobile laboratory service, X-ray with image intensifying and screening facilities, stress echocardiography and periodic medical check-up scheme. Its subsidiaries include Asiri Central Hospitals Ltd., Asiri Hospital Matara (Pvt) Ltd and Hemas Southern Hospitals (Private) Limited.
Company Coordinates stock-summary
Company Details
181, Kirula Road, Colombo 5 , COLOMBO None : 05
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Ashok Pathirage
Chairman of the Board, Managing Director
Dr. Karunamuni Karunaratne
Chief Executive Officer, Executive Director
Dr. Sivakumar Selliah
Non-Executive Independent Deputy Chairman of the Board
Mr. Vishal Bali
Non-Executive Nominee Director of TPG Growth III SF Pte. Ltd.
Mr. Ankur Thadani
Non-Executive Director
Mr. Sudarshan Ahangama
Non-Executive Independent Director
Mr. G. Premaratne
Non-Executive Independent Director
Mr. Samantha Rajapaksa
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
8,720 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,226 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

LKR 35,491 Million (Large Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.84

stock-summary
Return on Equity

18.05%

stock-summary
Price to Book

1.62